These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. High Frequency of Variants of Candidate Genes in Black Africans with Low Renin-Resistant Hypertension. Jones ES; Spence JD; Mcintyre AD; Nondi J; Gogo K; Akintunde A; Hackam DG; Rayner BL Am J Hypertens; 2017 May; 30(5):478-483. PubMed ID: 28052878 [TBL] [Abstract][Full Text] [Related]
25. Screening Rates for Primary Aldosteronism in Resistant Hypertension: A Cohort Study. Jaffe G; Gray Z; Krishnan G; Stedman M; Zheng Y; Han J; Chertow GM; Leppert JT; Bhalla V Hypertension; 2020 Mar; 75(3):650-659. PubMed ID: 32008436 [TBL] [Abstract][Full Text] [Related]
34. Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension? Connell JM; Fraser R; MacKenzie S; Davies E Hypertension; 2003 May; 41(5):993-9. PubMed ID: 12654713 [TBL] [Abstract][Full Text] [Related]
35. Aldosterone Synthase Inhibitors and the Treatment of Essential Hypertension. Gomez-Sanchez CE; Gomez-Sanchez EP J Clin Endocrinol Metab; 2023 Jul; 108(8):e638-e639. PubMed ID: 36740773 [No Abstract] [Full Text] [Related]
36. Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data. Black HR Am Heart J; 2004 Apr; 147(4):564-72. PubMed ID: 15077068 [TBL] [Abstract][Full Text] [Related]
37. Role of the renin-angiotensin-aldosterone system in collecting duct-derived endothelin-1 regulation of blood pressure. Ge Y; Huang Y; Kohan DE Can J Physiol Pharmacol; 2008 Jun; 86(6):329-36. PubMed ID: 18516095 [TBL] [Abstract][Full Text] [Related]